tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AbCellera Biologics Advances Clinical Trials and Revenue Growth
PremiumCompany AnnouncementsAbCellera Biologics Advances Clinical Trials and Revenue Growth
2M ago
AbCellera Biologics: Promising Pipeline and Strategic Focus Justify Buy Rating
Premium
Ratings
AbCellera Biologics: Promising Pipeline and Strategic Focus Justify Buy Rating
2M ago
AbCellera Biologics Reports Q2 2025 Financial Results
Premium
Company Announcements
AbCellera Biologics Reports Q2 2025 Financial Results
2M ago
AbCellera Biologics Receives Health Canada Approval for Trial
PremiumCompany AnnouncementsAbCellera Biologics Receives Health Canada Approval for Trial
4M ago
AbCellera receives Health Canada authorization to initiate ABCL575 Phase 1 trial
Premium
The Fly
AbCellera receives Health Canada authorization to initiate ABCL575 Phase 1 trial
4M ago
AbCellera price target lowered to $10 from $28 at Truist
Premium
The Fly
AbCellera price target lowered to $10 from $28 at Truist
5M ago
AbCellera Biologics: Promising Antibody Discovery with Strong Liquidity and Strategic Partnerships
PremiumRatingsAbCellera Biologics: Promising Antibody Discovery with Strong Liquidity and Strategic Partnerships
5M ago
AbCellera Biologics Navigates Progress and Challenges in Earnings Call
Premium
Company Announcements
AbCellera Biologics Navigates Progress and Challenges in Earnings Call
5M ago
AbCellera price target lowered to $8 from $10 at Stifel
Premium
The Fly
AbCellera price target lowered to $8 from $10 at Stifel
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100